from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1441c/PE_PGRS26

LFCtreatmentdescriptionclass of inhibitor

1.524

Amikacinug/mL Amikacintranslation

2.614

Cap5-10ug/mL Capreomycintranslation

1.878

Rox10-50 ug/mL Roxithromycintranslation

0.208

SM2-5 ug/mL Streptomycintranslation

3.558

Tet5-10 ug/mL Tetracyclinetranslation

0.520

Rif0.2-5ug/mL Rifampicintranscription

0.330

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.011

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.164

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.448

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.515

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.827

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.261

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.934

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.572

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.423

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.158

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.001

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.554

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.243

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.852

KCN5-20 ug/mL Potassium cyaniderespiration

-1.085

NaN30.2-2 mM Sodium aziderespiration

-0.321

Nigericin50 uM Nigericinrespiration

-0.069

TRC10-150 ug/mL Triclosanrespiration

-0.264

TRZ10-25 ug/mL Thioridazinerespiration

-0.732

Valinomycin0.5-10 uM Valinomycinrespiration

5.024

ZnSO42 mM ZnSO4respiration

0.486

menadione6-10 ug/mL Menadionerespiration

-0.259

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.369

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.163

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.270

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.697

NRP_1Non-replicating persistence stage 1dosRassociated

0.107

Amp0.2mg/mL AmpicillincellWall

0.225

Cephalexin20-100 ug/mL CephalexincellWall

0.779

Cerulenin0.32-5 ug/mL CerulenincellWall

1.109

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.721

EMB10-20 ug/mL EthambutolcellWall

-0.072

Eta12-40 ug/mL EthionamidecellWall

0.108

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.483

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.615

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.327

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.708

BZA0.12 mg/mL BenzamidearomaticAmides

-0.070

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.762

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.094

H2O24 mM hydrogen peroxideDNAdamaging

-0.070

Levo10 ug/mL LevofloxacinDNAdamaging

0.311

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.684

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.144

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.240

UVUV-irradiationDNAdamaging

-0.418

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.057

Antimycin12.5-50 ug/mL Antimycin A?

-0.773

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.401

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.564

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.701

PA8240.2-2 ug/mL PA-824?

-0.560

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.004

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.030

Verapamil50 uM Verapamil?

-0.076

mercaptoethanol2 mM 2-Mercaptoethanol?

0.067

methoxatin10-20 ug/mL Methoxatin?